Slingshot members are tracking this event:
International Phase 3 Study Results of RLX030 (seralaxin) for Acute Heart Failure Due 2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Mar 02, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Data, Rlx030, Seralaxin, Acute Heart Failure